这页已由机器翻译。其他页面可能仍然显示为英文。 View in English

脂肪酸结合蛋白作为人类癌症预后的潜在生物标志物

Yuting Guan ¹, Jiaxin Tan ², Zudong Xu ³

¹Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
²Department of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
³Guangxi Medical University, Nanning, Guangxi, China.
⁴Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
⁵Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.
⁶Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning, China.
⁷Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. huangqiongguang@stu.gxmu.edu.cn.
⁸Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China. huangqiongguang@stu.gxmu.edu.cn.
⁹Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning, China. huangqiongguang@stu.gxmu.edu.cn.

⁰Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Scientific Reports +

|

2025年九月1日

在PubMed上查看摘要

概括

脂肪酸结合蛋白 (FABP) 在不同癌症中表现不同,与药物敏感性相关. FABP家族基因为癌症预后提供预测价值,并可指导精确瘤治疗.

科学领域

癌症学
基因组学
分子生物学

背景情况

脂肪酸结合蛋白 (FABP) 与癌症进展有关,但它们在不同癌症类型中的具体作用尚未完全理解.
研究FABP家族基因表达和功能对于推进癌症研究和治疗策略至关重要.

研究的目的

使用TCGA数据分析各种癌症中FABP家族基因的表达模式.
评估FABP基因表达与抗癌药物敏感性,免疫亚型,瘤微环境和干性之间的关联.
探索FABP基因在泛癌分析中的预后价值,特别是肝细胞癌 (HCC).

主要方法

使用癌症基因组图谱 (TCGA) 数据库进行全面的基因表达分析.
进行生存分析 (Kaplan-Meier方法) 来评估预后值.
实时对人类HCC样本进行定量PCR验证.

主要成果

FABP家族基因在不同癌症类型和组织中表现出显著的异质性,特别是在BRCA和HCC中.
对多种抗癌药物的敏感性具有积极的相关性.
FABP基因与免疫亚型,干性和瘤微环境密切相关,显示出预测性预后价值.
在HCC中,FABP4,FABP5,FABP9和FABP12的放大和删除频率很高.

结论

FABP家族基因具有显著的异质性,与药物敏感性和胰腺癌的临床结果有关.
FABP家族基因与免疫特征和干性有关,具有作为生物标志物的潜力.
由于FABP3和FABP5是HCC的预后因素,因此需要进一步研究以进行精确的诊断和治疗.

关键词:

脂肪酸结合蛋白肝细胞癌免疫亚型胰腺癌预测情况

相关概念视频

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...